Offer - Urjas Oil for just ₹ 1 X
Sildobig D is an allopathic medicine The correct dosage of Sildobig D depends on the patient's age, gender, and medical history. This information has been provided in detail in the dosage section.
Sildobig D is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult(Male) |
|
Geriatric |
|
Is the use of Sildobig D safe for pregnant women?
Sildobig D has many dangerous side effects in pregnant women. If you are pregnant, do not consume Sildobig D without medical advice.
Is the use of Sildobig D safe during breastfeeding?
Taking Sildobig D may lead to serious side effects if you are breastfeeding. Sildobig D should not be taken by breastfeeding women unless prescribed by the doctor.
What is the effect of Sildobig D on the Kidneys?
Using Sildobig D does not have any harmful effects on kidneys.
What is the effect of Sildobig D on the Liver?
The liver can be affected by Sildobig D. If you experience any unwanted effects of this drug, stop taking it and consult your doctor. You should restart Sildobig D only after medical advice.
What is the effect of Sildobig D on the Heart?
Sildobig D is completely safe for the heart.
Sildobig D should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Sildobig D unless your doctor advises you to do so -
Is this Sildobig D habit forming or addictive?
Sildobig D is not addictive in nature.
Interaction between Food and Sildobig D
Due to the absence of research, it is difficult to say how Sildobig D and food will interact.
Interaction between Alcohol and Sildobig D
Information about the interaction of Sildobig D and alcohol is not currently available because this topic has not been researched yet.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Rapaflo® (silodosin)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1137-1138
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 476-477
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 303
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Avodart® (dutasteride)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Jalyn (dutasteride and tamsulosin hydrochloride)